Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,197 | -69,746 | -28,796 | -102,329 | -65,175 |
| Depreciation Amortization | -780 | -552 | -543 | -4,837 | -4,465 |
| Accounts payable and accrued liabilities | -4,966 | -3,545 | -4,592 | 4,269 | 963 |
| Other Working Capital | -8,113 | -1,087 | -7,362 | 11,653 | 3,432 |
| Other Operating Activity | 13,614 | 8,977 | 7,172 | 5,029 | 6,245 |
| Operating Cash Flow | $-96,442 | $-65,953 | $-34,121 | $-86,215 | $-59,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 107,771 | 67,260 | 28,768 | 48,043 | 18,380 |
| PPE Investments | -88 | -88 | -79 | -16 | -16 |
| Investing Cash Flow | $107,683 | $67,172 | $28,689 | $48,027 | $18,364 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | N/A | -739 | -739 |
| Common Stock Issued | 37 | 37 | 37 | 7,938 | 7,938 |
| Common Stock Repurchased | -73 | -73 | -73 | -41 | -32 |
| Other Financing Activity | 0 | 0 | 0 | -230 | -230 |
| Financing Cash Flow | $-36 | $-36 | $-36 | $6,928 | $6,937 |
| Beginning Cash Position | 35,859 | 35,859 | 35,859 | 67,119 | 67,119 |
| End Cash Position | 47,064 | 37,042 | 30,391 | 35,859 | 33,420 |
| Net Cash Flow | $11,205 | $1,183 | $-5,468 | $-31,260 | $-33,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -96,442 | -65,953 | -34,121 | -86,215 | -59,000 |
| Capital Expenditure | -88 | -88 | -79 | -16 | -16 |
| Free Cash Flow | -96,530 | -66,041 | -34,200 | -86,231 | -59,016 |